Machine learning is transforming clinical trial monitoring from slow, manual oversight into real-time, predictive decision-making. As decentralized designs, digital biomarkers, and regulatory expectations evolve, the industry is entering a new era where data integrity, responsiveness, and automation are no longer optional—they’re essential.

Explore the real costs, risks, and ROI of building versus buying an AI-powered regulatory documentation system—and why a hybrid approach often wins

Generative AI is rapidly making its mark in professional writing, but a critical question remains: is it actually doing the work, or...